Antimicrobial Drugs and Microbial Resistance: Principles, History, and Clinical Relevance

Microbial Resistance Threats in the United States (2021-2022)

Overview of Major Resistant Pathogens

Antimicrobial resistance (AMR) is a significant public health threat, with several pathogens showing increased resistance in recent years. The CDC monitors and reports on the burden of these threats in healthcare settings.

• Carbapenem-resistant Enterobacterales (CRE): Gram-negative bacteria resistant to carbapenem antibiotics.

• Carbapenem-resistant Acinetobacter: Notable for hospital-acquired infections.

• Candida auris: A multidrug-resistant fungus causing severe infections.

• Methicillin-resistant Staphylococcus aureus (MRSA): Resistant to beta-lactam antibiotics.

• Vancomycin-resistant Enterococcus (VRE): Resistant to vancomycin, a last-resort antibiotic.

• Extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales: Produce enzymes that break down many beta-lactam antibiotics.

• Multidrug-resistant (MDR) Pseudomonas aeruginosa: Resistant to multiple classes of antibiotics.

Example: The emergence of Candida auris in healthcare settings demonstrates the challenge of treating infections with limited therapeutic options.

Principles of Antimicrobial Therapy

Antimicrobial Chemotherapy

Antimicrobial chemotherapy involves administering drugs to eliminate infectious agents without harming the host's cells. The goal is selective toxicity.

• Selective toxicity: The drug should target the pathogen but not the host.

• Microbicidal vs. Microbistatic: Microbicidal drugs kill microbes, while microbistatic drugs inhibit their growth. Microbicidal drugs are generally preferred for severe infections.

Example: Penicillin is selectively toxic to bacteria due to its action on peptidoglycan synthesis, which is absent in human cells.

Characteristics of the Ideal Antimicrobial Drug

The ideal antimicrobial drug should possess several key properties to maximize efficacy and minimize harm.

Characteristic	Description
Selectively toxic	Targets microbe, not host cells
Microbicidal	Kills rather than inhibits microbes
Stable	Remains potent and is not broken down prematurely
Low resistance potential	Not easily subject to resistance development
Active in body fluids	Effective even when diluted
Reasonably priced	Accessible for widespread use
Minimal side effects	Does not disrupt host health or cause allergies

History of Chemotherapy

Key Milestones in Antimicrobial Drug Discovery

The development of antimicrobial drugs has revolutionized the treatment of infectious diseases.

• Salvarsan: Discovered by Ehrlich and Hata, an arsenic-containing compound for syphilis.

• Penicillin: Discovered by Alexander Fleming from Penicillium notatum; first antibiotic used clinically.

• Prontosil: Discovered by Klarer, Mietzsch, and Domagk; a red dye effective against strep and staphylococcal infections.

• Sulfanilamide: First synthetic antimicrobial agent.

• Dorothy Hodgkin: Used X-ray crystallography to analyze natural product structures, aiding drug development.

Example: The clinical introduction of penicillin marked the beginning of the antibiotic era, drastically reducing mortality from bacterial infections.

Definitions and Key Terms

• Antibiotics: Substances produced by microorganisms that inhibit or destroy other microbes.

• Synthetic antimicrobials: Chemically modified derivatives of natural compounds to improve efficacy and reduce toxicity.

• Antimicrobial chemotherapy: Use of drugs to control infection.

• Prophylaxis: Use of drugs to prevent infection in high-risk individuals.

Example: PrEP (pre-exposure prophylaxis) uses antiretroviral drugs to prevent HIV infection in high-risk populations.

Additional info:

• Antimicrobial resistance is driven by genetic adaptability and misuse of antibiotics in healthcare and agriculture.

• Clinical trials and drug development are challenged by the need for selective toxicity and the rapid emergence of resistance.